The Treatment of Hairy Cell Leukemia

November 26, 2013
Jae Park, MD

Jae Park, MD, attending physician, Leukemia Service, Memorial Sloan-Kettering Cancer Center, comments on the treatment of patients with hairy cell leukemia.

Clinical Pearls

Jae Park, MD, attending physician, Leukemia Service, Memorial Sloan-Kettering Cancer Center, comments on the treatment of patients with hairy cell leukemia.

  • Patients with hairy cell leukemia typically receive cladribine or pentostatin and experience a long remission
  • Patients are able to respond again to cladribine or pentostatin following relapse
  • There are limited options for those who have gone through many lines of therapy